Health
Antibody Cocktail Seems to Prevent COVID-19 Spread – Medscape
The antibody cocktail casirivimab and imdevimab may be an option to ward off infection, but the study didn’t quite reach statistical significance.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
A one-time injection of the monoclonal antibody cocktail casirivimab with imdevimab (REGEN-COV), taken within 72 hours of a household member’s diagnosis with SARS-CoV-2, prevented 100% of COVID-19 illness, 100% of high SARS-CoV-2 viral loads, and cut length of asymptomatic infection to 1 week.
“It’s fantastic news,” said Rajesh Gandhi, MD, an infectious disease physician at Massachusetts General…
-
Noosa News2 hours agoAustralian Idol 2025 winner draws crowd for Noosa pop up show
-
General2 hours agoNew US tariffs on semiconductors coming ‘over the next week’, Donald Trump says
-
Noosa News11 hours agoWoman dies, 10 rushed to hospital after Bald Hills collision
-
General23 hours agoDozens dead in Ukraine’s Sumy after Russian strike, acting mayor says